2 days Evolus, An AbbVie And Botox Rival, Just Hit The Stratosphere — Here’s Why Investor's Business Daily

   X     

1 week Why the Market Dipped But AbbVie (ABBV) Gained Today Zacks

   X     

1 week The Zacks Analyst Blog Highlights Visa, AbbVie, Analog Devices and Precipio Zacks

   X     

1 week Regenxbio: Wet AMD ABBV-RGX-314 Results Remain On Track For 2026 Seeking Alpha

   X     

1 week Top Research Reports for Visa, AbbVie & Analog Devices Zacks

   X     

1 week AbbVie Inc. (ABBV) J.P. Morgan 43rd Annual Healthcare Conference (Transcript) Seeking Alpha

   X     

1 week AbbVie Falls 8% in 3 Months: Buy, Hold or Sell the Stock? Zacks

   X     

1 week AbbVie Has Immense Cash Flow Potential Seeking Alpha

   X     

2 weeks AbbVie Takes $3.5B Impairment Charge for Failed Schizophrenia Drug Yahoo Finance

   X     

2 weeks AbbVie’s Stock Is Unfairly Cheap Seeking Alpha

   X     

2 weeks Opinion on my current portfolio Reddit

   X     

2 weeks AbbVie (ABBV) Stock Moves -0.32%: What You Should Know Zacks

   X     

2 weeks Will AbbVie (ABBV) Beat Estimates Again in Its Next Earnings Report? Zacks

   X     

2 weeks AbbVie cuts 2024 profit forecast on acquisition expenses Investing.com

   X     

3 weeks The Zacks Analyst Blog Eli Lilly, J&J, AbbVie, AstraZeneca and Pfizer Zacks

   X     

3 weeks AbbVie (ABBV) Gains As Market Dips: What You Should Know Zacks

   X     

3 weeks Brokers Suggest Investing in AbbVie (ABBV): Read This Before Placing a Bet Zacks

   X     

3 weeks AbbVie Inc. (ABBV) Is a Trending Stock: Facts to Know Before Betting on It Zacks

   X     

1 month AbbVie (ABBV) Rises Yet Lags Behind Market: Some Facts Worth Knowing Zacks

   X     

1 month Pharma Stock Roundup: PFE’s 2025 Outlook, MRK & ABBV’s M&A Deals Zacks

   X     

1 month Investors Heavily Search AbbVie Inc. (ABBV): Here is What You Need to Know Zacks

   X     

1 month AbbVie Takes On Pfizer And Merck With Its Next Leg Of Growth. Will AbbVie Stock Come Back? Investor's Business Daily

   X     

1 month AbbVie (ABBV) Stock Declines While Market Improves: Some Information for Investors Zacks

   X     

1 month AbbVie: Pullback Is A Golden Opportunity For Dividend And Growth Investors Seeking Alpha

   X     

1 month ABBV’s Acquisition Spree Continues: Buy, Sell or Hold the Stock? Zacks

   X     

1 month ABBV to Acquire Nimble Therapeutics to Strengthen Immunology Pipeline Zacks

   X     

1 month Betting Big On AbbVie: A Prescription For Growth And Dividends Seeking Alpha

   X     

1 month AbbVie’s Recently Acquired Parkinson’s Drug Meets Third Study Goal Zacks

   X     

1 month The Zacks Analyst Blog Highlights Eli Lilly, AbbVie, Gilead Sciences, Air T and Fossil Group Zacks

   X     

2 months Top Stock Reports for Eli Lilly, AbbVie & Gilead Sciences Zacks

   X     

2 months AbbVie’s third successful Parkinson’s trial sets the stage for an eventful 2025 MarketWatch

   X     

2 months AbbVie reports positive results in Parkinson’s trial Investing.com

   X     

2 months Calls of the Day: Toast, Abbvie, Berkshire Hathaway YouTube

   X     

2 months AbbVie Inc. (ABBV) Citi’s 2024 Global Healthcare Conference (Transcript) Seeking Alpha

   X     

2 months Here is What to Know Beyond Why AbbVie Inc. (ABBV) is a Trending Stock Zacks

   X     

2 months Why Dividend Aristocrats Like Walmart, ADP, and AbbVie Are Set to Outperform Yahoo Finance

   X     

2 months Why Is AbbVie (ABBV) Down 10.2% Since Last Earnings Report? Zacks

   X     

2 months Despite Neuroscience Setback, AbbVie Has Strong Recovery Ahead Seeking Alpha

   X     

2 months AbbVie Stock Rises After Leerink Partners Upgrades Its Rating Zacks

   X     

2 months AbbVie: Upgrading To ‘Strong Buy’ After Pullback Seeking Alpha

   X     

2 months Trade Tracker: Jim Lebenthal buys more Abbvie YouTube

   X     

2 months AbbVie Jumps 5% On An Upgrade Despite Bristol Myers-Tied Setback Investor's Business Daily

   X     

2 months AbbVie, Nvidia Lead Friday’s Market Cap Stock Movers Investing.com

   X     

2 months Is Trending Stock AbbVie Inc. (ABBV) a Buy Now? Zacks

   X     

2 months Where Will AbbVie Be in 5 Years? Yahoo Finance

   X     

2 months AbbVie’s Ovarian Cancer Drug Elahere Gets Approval in Europe Zacks

   X     

2 months Dividend King AbbVie Just Paid Investors: Here’s How Much They Got 24/7 Wall St.

   X     

2 months Pharma Stock Roundup: AZN, BAYRY’s Earnings, ABBV’s Pipeline Setback Zacks

   X     

2 months AbbVie Stock Falls 11% in a Month: Should You Buy the Dip? Zacks

   X     

2 months Final Trades: Bitcoin, Abbvie and Baker Hughes YouTube

   X     

2 months Aldeyra’s FDA Resubmission And AbbVie Option Revitalize Reproxalap’s Prospects Seeking Alpha

   X     

2 months AbbVie’s Schizophrenia Failure Disappoints But Analysts Show Confidence In Immunology Portfolio Yahoo Finance

   X     

2 months Final Trades: Lyft, Meta, United States Oil Fund & Abbvie YouTube

   X     

2 months AbbVie And Pfizer: Q3 Dividend Checkup Post-Earnings Seeking Alpha

   X     

2 months Is AbbVie Still A Strong Buy After Fantastic Gains? (Rating Downgrade) Seeking Alpha

   X     

2 months AbbVie Stock: Keep Calm And Buy The Dip Seeking Alpha

   X     

2 months Bristol Rockets 11% As Investors Question AbbVie’s $8.7 Billion ‘Mistake’ Investor's Business Daily

   X     

2 months AbbVie Tumbles After New Schizophrenia Drug Fails Two Trials Yahoo Finance

   X     

3 months RHHBY or ABBV: Which Is the Better Value Stock Right Now? Zacks

   X     

3 months Analyst Report: AbbVie Inc Yahoo Finance

   X     

3 months Market Digest: THRM, DINO, KLAC, OKE, RJF, SYK, META, ABBV, NCLH Yahoo Finance

   X     

3 months Pharma Stock Roundup: MRK, PFE, ABBV, NVS, LLY’s Q3 Earnings in Focus Zacks

   X     

3 months AbbVie (NYSE:ABBV) Releases Quarterly Earnings Results, Beats Estimates By $0.08 EPS MarketBeat

   X     

3 months AbbVie: 3 Positives From The Earnings Report Seeking Alpha

   X     

3 months AbbVie Inc. (NYSE:ABBV) Short Interest Up 8.9% in October MarketBeat

   X     

3 months AbbVie Trumps Q3 Earnings & Sales Estimates, Raises ’24 EPS View Zacks

   X     

3 months AbbVie (NYSE:ABBV) Stock Price Up 3.2% After Dividend Announcement MarketBeat

   X     

3 months Compared to Estimates, AbbVie (ABBV) Q3 Earnings: A Look at Key Metrics Zacks

   X     

3 months AbbVie raises 2024 profit forecast on strong sales of key drugs Skyrizi, Rinvoq Investing.com

   X     

3 months AbbVie Has A New Cash Cow As Humira Bows To Skyrizi In Third-Quarter Beat Investor's Business Daily

   X     

3 months Will These 5 Big Drug Stocks Surpass Q3 Earnings Forecasts? Zacks

   X     

3 months AbbVie (NYSE:ABBV) Shares Up 1.1% After Analyst Upgrade MarketBeat

   X     

3 months First American Bank Cuts Stake in AbbVie Inc. (NYSE:ABBV) MarketBeat

   X     

3 months Hamlin Capital Management LLC Buys 76,218 Shares of AbbVie Inc. (NYSE:ABBV) MarketBeat

   X     

3 months Mediolanum International Funds Ltd Reduces Stock Position in AbbVie Inc. (NYSE:ABBV) MarketBeat

   X     

3 months Final Trades: Tesla, Sweetgreen, AbbVie and Digital Realty YouTube

   X     

3 months AbbVie (ABBV) Outperforms Broader Market: What You Need to Know Zacks

   X     

3 months AbbVie (NYSE:ABBV) Stock Price Up 1% – What’s Next? MarketBeat

   X     

3 months Private Advisor Group LLC Reduces Stock Position in AbbVie Inc. (NYSE:ABBV) MarketBeat

   X     

3 months AbbVie (NYSE:ABBV) Stock Price Down 0% – Here’s What Happened MarketBeat

   X     

3 months Foundations Investment Advisors LLC Has $12.81 Million Position in AbbVie Inc. (NYSE:ABBV) MarketBeat

   X     

3 months AbbVie: Strong Dividends But Humira Disappoints Seeking Alpha

   X     

3 months The Zacks Analyst Blog Highlights Johnson & Johnson, Pfizer, Roche, AbbVie and Sanofi Zacks

   X     

3 months AbbVie (NYSE:ABBV) Shares Down 0.5% – Time to Sell? MarketBeat

   X     

3 months Vest Financial LLC Buys 24,610 Shares of AbbVie Inc. (NYSE:ABBV) MarketBeat

   X     

3 months Zacks Research Comments on AbbVie’s Q3 Earnings (NYSE:ABBV) MarketBeat

   X     

3 months Creative Planning Buys 40,925 Shares of AbbVie Inc. (NYSE:ABBV) MarketBeat

   X